Part I: General Information




Скачать 246.67 Kb.
НазваниеPart I: General Information
страница1/5
Дата13.10.2012
Размер246.67 Kb.
ТипДокументы
  1   2   3   4   5
1CURRICULUM VITAE


PART I: General Information


DATE PREPARED: March 3, 2011

Name: A. Oliver Sartor, M.D

Home Address: 1511 Dufossat Street, New Orleans, LA 70115

Work E-Mail: osartor@tulane.edu

Place of Birth: Shreveport, LA


Education:

1977 B.A. Colorado College, Colorado Springs, CO

1982 M.D. Tulane University School of Medicine, New Orleans, LA


Postdoctoral Training:

1982-1983 Intern in Pediatrics, Children’s Hospital of Philadelphia, University of Pennsylvania Pediatrics Program, Philadelphia, PA

1983-1984 Intern in Medicine, Tulane University School of Medicine

1984-1985 Junior Resident, Internal Medicine, Tulane University School of Medicine

1985-1986 Senior Resident, Internal Medicine, Tulane University School of Medicine

1986-1989 Fellow in Medical Oncology, National Cancer Institute, Bethesda, MD

1989-1990 Senior Staff Fellow, Laboratory of Cellular Development and Oncology, National Institutes of Dental Research, Bethesda, MD


Licensure and Certification:

1985- Louisiana Medical Licensure

1986-lifetime American Board of Internal Medicine Certificate

1989-lifetime American Board of Internal Medicine, Medical Oncology Certificate

1986-1993 Maryland Medical Licensures

1988-1990 Virginia Medical Licensures

2006-2008 Massachusetts Medical Licensure


Academic Appointments:

1990-1993 Senior Investigator, Clinical Pharmacology Branch, National Cancer Institute, Bethesda, MD

1993-1998 Associate Professor of Medicine (with tenure), Section of Hematology/Oncology, Departments of Medicine and Urology, Louisiana State University School of Medicine, Shreveport, LA

1998-2006 Patricia Powers Strong Professor of Oncology (with tenure), Louisiana State University School of Medicine, New Orleans, LA

2002-2006 Adjunct Clinical Professor of Medicine, Tulane University School of Medicine, New Orleans, LA

2006-2007 Associate Professor of Medicine, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA

2007-2008 Lecturer, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA

2008-2010 Piltz Endowed Professor of Cancer Research in Depts. of Medicine and Urology), Professor of Medicine and Urology, Tulane Medical School, New Orleans, LA

2010- C.E. and Bernadine Laborde Professor of Cancer Research and Medical Director, Tulane Cancer Center


Hospital Appointments:

1990-1993 Attending Physician, NIH Clinical Center, Bethesda, MD

1993-1998 Attending Physician, Louisiana State University Hospital, Shreveport, LA

1993-1998 Attending Physician, Willis-Knighton Hospital, Shreveport, LA

1998-2006 Attending Physician, Medical Center of Louisiana at New Orleans, New Orleans, LA

1998-2006 Attending Physician, Memorial Medical Center, New Orleans, LA

2006-2007 Attending Physician, Dana Farber Cancer Institute, Boston, MA

2006-2007 Attending Physician, Brigham and Women’s Hospital, Boston, MA

2008- Attending Physician, Tulane University Hospital, New Orleans, LA


Hospital and Health Care Organization Service Responsibilities:

1998-2006 Head, LSU Oncology Services, Medical Center Louisiana, New Orleans


Major Administrative Responsibilities:

1998-2006 Chief, Hematology/Oncology Section, Department of Medicine, Louisiana State University School of Medicine

1998-2006 Director, Stanley S. Scott Cancer Center, Louisiana State University Health Sciences Center

2002-2006 Co-Director, Louisiana Cancer Research Consortium (comprised of both Louisiana State University Health Sciences Center in New Orleans and Tulane Health Sciences Center, New Orleans, LA)

2006-2007 Director, Clinical Trials Unit, Lank Center for Genitourinary Oncology, Dana Farber Cancer Institute

2010- Medical Director, Tulane Cancer Center


Major Committee Assignments:

1993-1998 Genitourinary Cancer Committee, Member, Southwestern Oncology Group

    1. Institutional Review Board, Member, Louisiana State University School of Medicine

1996-1998 Medical School Admissions Committee, Member, Louisiana State University School of Medicine

1997-1998 Institutional Review Board, Chairman, Louisiana State University School of Medicine

1998-2006 Louisiana Cancer and Lung Trust Fund Board, Member, (Board Appointed by the Governor of Louisiana)

1999-2002 Promotion and Tenure Committee, Member, Department of Medicine, Louisiana State University Health Sciences Center

2000-2002 Promotion and Tenure Committee, Chairman, Department of Medicine, Louisiana State University Health Sciences Center

2001-2005 Clinical Faculty Advisory Committee to the LSU Health Care Network, member, Louisiana State University Health Sciences Center

2003-2009 The Comprehensive Multicenter Prostate Adenocarcinoma Registry (COMPARE), Co-Chairman, sponsored by sanofi-aventis.

2003-2005 Louisiana Cancer and Lung Trust Fund Board, Chairman, 2004 (Board Appointed by the Governor of Louisiana)

2003-2006 Executive Committee, Member, Louisiana Cancer Control Partnership

2003-2006 Finance Committee, Member, LSU Health Care Network (organization responsible for overall billing and collections at the LSU Medical School, New Orleans)

2003-2006 Contracts Committee, Member, LSU Health Care Network (responsible for insurance/managed care contracting at the LSU Medical School, New Orleans)

2005-2006 Investment Strategic Planning Committee, ad hoc Member, LSU Health Sciences Center Foundation (LSU endowment investments)

2006- Medical Oncology, Co-Chairman, Genitourinary Cancer Committee, Radiation Therapy Oncology Group (RTOG)

2006- Medical Oncology Committee, Radiation Therapy Oncology Group (RTOG)

2008- Louisiana Cancer and Lung Trust Fund Board, (Board Appointed by the Governor of Louisiana)

2008- Institutional Review Board member, Tulane Medical School

2009- LCRC Tissue Utilization Committee

2010- Tulane Cancer Center Executive Committee

2010- Chairman, Tulane Cancer Center Strategic Planning Committee


Teaching leadership:

1990-1993 Medical Oncology Attending, National Cancer Institute, Bethesda, MD, inpatient oncology service ~2 months/year (fellows)

1990-1993 Medical Oncology Attending, National Cancer Institute, Bethesda, MD, outpatient oncology clinics, 12 months/year (fellows)

1993-1998 Medical Oncology Attending, LSU Medical School and VA Medical Center, Shreveport, LA, inpatient oncology service ~2 months/year (fellows, residents, students)

1993-1998 Medical Oncology Attending, outpatient oncology attending, LSU Medical School and VA Medical Center, Shreveport, LA, outpatient oncology service, 12 months/year (fellows, residents a portion of the time)

1998-2005 Medical Oncology Attending, LSU Medical School, New Orleans, LA, inpatient oncology service ~2 months/year (fellows, residents, students)

1998-2005 Medical Oncology Attending, outpatient oncology attending, LSU Medical School, New Orleans, LA, outpatient oncology service, 12 months/year (fellows, residents a portion of the time)

2006-2007 Medical Oncology Attending, Solid Tumor Service, Brigham & Women's Hospital, Boston, MA, 4-6 weeks/year (residents)

2006-2007 Medical Oncology Attending, outpatient GU oncology clinics, Dana-Farber Cancer Institute, Boston, MA, 12 months/year (fellows, a portion of the time)

2008- Tulane Cancer Center Attending, Inpatient and outpatient services


Scientific Advisory Boards:

1999- Center for Prostate Disease Research-Walter Reed Hospital & US Department of Defense, Washington, DC

2000-2004 Atrix Laboratories, Ft. Collins, CO

2000-2006 Metastatin Pharmaceuticals, Washington, DC

2004-2006 Patient Advocates Against Advanced Cancer (PAACT),

Grand Rapids, MI

2004- Theralogix, Rockville, MD

2006- Prostate Cancer Prevention Trial P01

2010- Bellicum


Miscellaneous ad hoc Advisory Boards and Consultant Agreements:

1993 Henri-Beaufour Institute (France)

1993-1995 Immunex (USA)

1995 DuPont (USA)

1996 Schering (USA)

1996-2008 Cytogen (USA)

1996 Debiopharm (Swiss)

1996 Janssen (USA)

1996-1998 Berlex (German)

2003-2009 GPC Biotech (German)

2003-2004 Atrix Laboratories (USA)

2003-2005 Bracco (Italy)

2004-2007 Negma-Lerads (France)

2004-2005 Abbott (USA)

2004- sanofi (France)

2004- Dendreon

2005 Novacea (USA)

2005 Astella (Japan)

2005 Novartis (Swiss)

2005-2006 Spectrum Pharmaceuticals (USA)

2006-2007 QLT, Inc. (Canada)

2006 Roche (Swiss)

2006-2007 Sermo (USA)

2006 TEVA (Israel)

2006-2009 GlaxoSmithKline (UK)

2006 General Electric (USA)

2007 Cleveland Biolabs (USA)

2007- Pfizer (USA)

2007-2008 Ausio Pharmaceuticals, LLC (USA)

2007- OncoGenex (Canada)

2007 Bind Biosciences (USA)

2007- Algeta (Norway)

2008 EUSA (USA)

2008- Tolmar (Argentina)

2009 Ascenta (USA)

2009 Takeda (Japan)

2009- Celgene

2009- BMS

2009- Medivation

2010 ExonHit

2010 Centocor (JNJ)


Independent Data Safety and Monitoring Committees:

2004-2009 Chairman, IDMC, Dendreon, Provenge Vaccine Trial 9902B phase III IMPACT study

2007-2009 Chairman, Dendreon, Provenge Vaccine Trial PO-7 Study

2006- IDMC (sole member), OncoGenex, OGX-427-01 Trial

2008-2010 Chairman, IDMC, Pfizer, A6181120 (Phase III study in hormone-refractory prostate cancer with sunitinib/prednisone versus prednisone

2008- IDMC, Pfizer, A4061032 (Phase III Trial of axitinib in metastatic renal cancer). Chairman, 2010-

2009- IDMC member, Celgene, Phase III MAINSAIL Study (Evaluation of efficacy and safety of docetaxel and prednisome with or without lenalidomide in subjects with castrate-resistant prostate cancer)

2009- Chairman, IDMC, Medivation, Affirm Phase III trial in castrate-refractory Prostate Cancer with MDV3100 versus Placebo

2010- Chairman, IDMC, TEVA, OGX-011 Docetaxel Trial


Special NCI Service:

2005 and 2008 Site Reviewer/Advisor: National Cancer Institute Intramural Medical Oncology Prostate Cancer Program


Community Service Related to Professional Work:

1998, 2002-2005 Executive Committee, “Key to the Cure” Fundraiser, Saks Fifth Avenue, New Orleans, LA

1998-2006, 2008 Komen Foundation, New Orleans Chapter, Board of Directors

1999 Louisiana Legislative Act 1357: Provides for health insurance coverage of certain cancer patients participating in federally sponsored clinical trials. Worked with Rep. Clarkson and testified for Legislative Committees, co-wrote legislation

2001 Louisiana Legislative Act 1116: Access to Mammography Act. Worked with Rep. Clarkson and testified for Legislative Committees, co-wrote legislation

2002 Louisiana Legislative Act 41 (2002 Special Session): Louisiana Cancer Research Consortium. Co-wrote legislation: Worked with Senate President, John Hainkel and Representative Mitch Landrieu; testified for various Legislative Committees.

2002 Louisiana Legislative Act 19: Tobacco Tax: Increased tax on cigarettes: Funds from three cents per pack of each cigarette sold in the state directed to support the Louisiana Cancer Research Consortium. Worked with Senate President, John Hainkel and Representative Mitch Landrieu; testified for various Legislative Committees and co-wrote legislation with Dr. Roy Weiner of Tulane.

2004-2006 Operations Co-Chair, Hope Lodge New Orleans, American Cancer Society Project

2005-2008 Advisory Board to the Honorary Consul from Louisiana to Canada

2005- PER Continuing Medical Education Advisory Board, Dallas, TX

2006-2008 Medical Advisory Committee, Massachusetts Prostate Cancer Coalition

2008- Komen Foundation, New Orleans, Board Member


Professional Societies:

~1987- American Society for Clinical Oncology

~1990- American Association for Cancer Research

~1994- American Urological Association

~1998- Society of Urologic Oncology

~2002- Society of Basic Urological Research


Editorial Boards:

1999-2001 The Prostate Journal

2002-2009 Clinical Prostate Cancer/Clinical Genitourinary Oncology

2002- CURE (Periodical for cancer patients: CURE has won multiple awards including Top 10 magazine launches in the USA, 2002; silver and gold Eddies Award for editorial excellence for consumer health magazine category, circulation between 250,000-500,000) .

2003-2006 Urology


Editor-in-Chief:

1997-1999 Advances in Prostate Cancer, PER Publications, Dallas, TX (CME)

2002-2005 Clinical Prostate Cancer (peer-reviewed, MEDLINE listed). Note: name change in 2006 to Clinical Genitourinary Cancer.

2003-2004 New Urology (CME)

2006- Clinical Genitourinary Cancer (Co-Chief Editor, peer-reviewed and MEDLINE listed)


Reviewer:

~1993- Journal of the National Cancer Institute

~1995- Journal of Clinical Oncology

~1998- Journal of Urology

~1998- Urology

~1999- The Prostate

~2000- Cancer

~2004- International Journal of Cancer

2006- Cancer Causes and Control

2006- Clinical Cancer Research

2007- New England Journal of Medicine

2008- Cancer Investigation

2008- British Journal of Urology International

2008 Molecular Cancer Therapeutics


National Study Sections (CDC, NIH, DOD)

1996-1998 Centers for Disease Control, Chronic Disease Program, member

1998-2004 Department of Defense-Prostate Cancer Study Section in Epidemiology/Behavioral Sciences, member

1998-2005 Ad hoc member of various PO1s, P20s, U54s, U56s, and P30s study sections. Reviewer of NCI designated cancer center grants-P30s at Fred Hutchinson-University of Washington, Seattle, WA and University of Pennsylvania, Philadelphia, PA

2006- Prostate Cancer Integration Panel, US Department of Defense (DOD): Oversees all peer-reviewed DOD funding for prostate cancer research in the United States

2006-2010 Elected to Executive Committee of the Prostate Cancer Integration Panel, US Department of Defense (DOD)

2008-2009 Chairman for 2008-2009, Prostate Cancer Integration Panel, US Department of Defense (DOD)


Awards and Honors:

  1. Alpha Omega Alpha (Springtime selectee and President of Tulane AOA Chapter)

1982 New Orleans Pediatric Society Award for outstanding ability in Pediatrics

1982 Hymen S. Mayerson Award for exceptional academic and/or research achievement in physiology as a medical student

1982 C.V. Mosby Book Award for outstanding scholarship as a medical student

1985 Outstanding teaching resident, Department of Medicine, Tulane Medical School

1985 First place prize for scientific presentation at the La. Chapter of the American College of Physicians

2002-2005 New Orleans "Best Doctors", by local New Orleans magazine

2004 Spirit Award Recipient, American Cancer Society, New Orleans, LA

2005- Best Doctors in America

2008- New Orleans “Best Doctors”, by local New Orleans magazine


  1   2   3   4   5

Похожие:

Part I: General Information iconPart IV draft information sheets sampling Information – handling requirements and preservation Information Sheet 1

Part I: General Information iconR e f e r e n c e m a t e r I a L s Reference materials are a great place to start if you aren’t sure of a topic, you need general information, or you need help with the language in general. Dictionaries

Part I: General Information iconPart 1 general 01 summary

Part I: General Information iconPart 1 general 1 references

Part I: General Information iconGeneral Challenge Discussions Topic Part II

Part I: General Information iconPart one: General Introduction and Historical b ackground

Part I: General Information iconGeneral information

Part I: General Information iconI. general information 1a. General Information

Part I: General Information iconI general information

Part I: General Information iconGeneral Information

Разместите кнопку на своём сайте:
Библиотека


База данных защищена авторским правом ©lib.znate.ru 2014
обратиться к администрации
Библиотека
Главная страница